Urokinase for Injection Manufacturers PAN India, Suppliers
Taj Pharma India: Leading Manufacturer & Exporter of Urokinase for Injection 5000IU (UVANTAJ)
Taj Pharmaceuticals Ltd, based in Vapi, Gujarat, stands at the forefront as one of the most reputed manufacturers, suppliers, and exporters of Urokinase for Injection 5000IU in India. With a steadfast commitment to high-quality standards, pharmaceutical compliance, and clinical safety, Taj Pharma has become a trusted name across India, Africa, the Middle East, and Latin America (LTAM).
What is Urokinase for Injection 5000IU (UVANTAJ)?
Urokinase for Injection 5000IU, marketed under the brand name UVANTAJ, is a thrombolytic medication used to dissolve blood clots in medical emergencies. This injectable formulation is administered in hospital settings to treat:
- Pulmonary embolism (PE)
- Deep vein thrombosis (DVT)
- Acute myocardial infarction (heart attack)
- Ischemic stroke
- Blocked catheters and dialysis lines
Urokinase acts by converting plasminogen to plasmin, which subsequently degrades fibrin clots. This restores normal blood flow, reducing the risk of tissue damage, permanent disability, or death.
Why Taj Pharma India is the Preferred Manufacturer of Urokinase Injection
Taj Pharmaceuticals Ltd is ISO, WHO-GMP, and EU-GMP certified, making it a trusted name in the international pharmaceutical market. Our Urokinase Injection 5000IU is manufactured in state-of-the-art facilities located in Vapi and Mumbai, ensuring the highest level of purity, stability, and efficacy.
Key highlights include:
- Stringent Quality Control & Assurance protocols
- Sterile, pyrogen-free production process
- Lyophilized powder for enhanced shelf-life and stability
- Compliance with pharmacopeial standards (USP, BP, IP)
- Regulatory support including COA, MOA, and MSDS documentation
- Customized packaging as per international market needs
Urokinase Injection – Therapeutic Applications and Advantages
Cardiovascular Emergencies
Urokinase Injection plays a life-saving role in acute myocardial infarction by dissolving coronary clots, thereby improving perfusion and reducing infarct size.
Pulmonary Embolism and Deep Vein Thrombosis
In cases of PE and DVT, Urokinase facilitates rapid dissolution of thrombi, reducing the chances of long-term complications like post-thrombotic syndrome.
Ischemic Stroke Treatment
Administered under specialized medical supervision, Urokinase restores cerebral blood flow, mitigating the extent of ischemic damage in eligible stroke patients.
Catheter Clearance
Used to clear occluded central venous catheters or dialysis machines, Urokinase ensures uninterrupted treatment, minimizing healthcare-associated risks.
Dosage and Administration Guidelines
Urokinase is administered intravenously (IV) under strict medical supervision. The dosage depends on the condition being treated, body weight, and individual clinical response. Typical dosing involves:
- Initial bolus dose followed by continuous infusion
- Monitoring of fibrinogen levels and bleeding risk
- Close patient observation during and after administration
Taj Pharma provides detailed pack inserts and prescribing information to ensure optimal use by healthcare professionals.
Safety Profile and Precautions
Urokinase Injection is generally well-tolerated, but clinicians must take appropriate precautions:
- Contraindicated in patients with active bleeding or recent surgery
- Use with caution in liver or kidney impairment
- Regular monitoring of coagulation parameters is essential
- Avoid simultaneous use with other anticoagulants unless necessary
Pregnancy and Breastfeeding
Animal data shows no significant teratogenic risk, and Urokinase is likely safe during pregnancy under medical advice. It is also considered probably safe during lactation, but consultation with a healthcare provider is recommended.
Taj Pharma’s Global Distribution Network
As one of the leading exporters of Urokinase for Injection, Taj Pharma proudly supplies to:
- Hospitals, clinics, and healthcare institutions across India
- African markets including Kenya, Nigeria, Ethiopia, and Ghana
- Middle Eastern countries like UAE, Saudi Arabia, and Jordan
- Latin America including Brazil, Colombia, and Mexico
Our extensive distribution network is backed by timely logistics, regulatory compliance, and end-to-end support for our clients.
Urokinase Injection PCD Franchise & Third Party Manufacturing
Taj Pharma offers attractive PCD pharma franchise opportunities and third-party contract manufacturing services for Urokinase 5000IU. Our franchise partners benefit from:
- Exclusive marketing rights
- Monopoly-based distribution
- Promotional inputs (MR bags, visual aids, LBLs, reminder cards)
- Reliable supply chain and timely product delivery
For third-party clients, we provide full-spectrum manufacturing services, from formulation development to regulatory documentation and packaging design.
Packaging Information
- Strength: 5000IU
- Dosage Form: Lyophilized Powder for Injection
- Route of Administration: Intravenous
- Packing: 1 Vial per box, with sterile water for injection
- Storage: Store below 25°C, protected from light and moisture
Regulatory & Certification Highlights
Taj Pharma’s Urokinase Injection complies with all major international and domestic regulatory standards:
- WHO-GMP Certified
- EU-GMP Approved
- DCGI, FDA India licensed
- Available with Dossier: CTD/eCTD format
- CEP/COA/MSDS available upon request
We maintain complete transparency and documentation, ensuring our partners always receive compliant and export-ready products.
Client Satisfaction and Industry Reputation
At Taj Pharmaceuticals, customer-centric service and ethical business practices form the cornerstone of our operations. Our long-standing relationships with healthcare providers and pharmaceutical importers are built on:
- Consistent product quality
- Unmatched technical support
- Prompt after-sales assistance
- Fair pricing policies
Contact Taj Pharma for Urokinase Injection 5000IU (UVANTAJ)
If you’re a pharmaceutical distributor, hospital procurement manager, or a PCD franchise seeker, Taj Pharma is your ideal partner for sourcing premium quality Urokinase for Injection 5000IU at competitive prices.
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
📍 Manufacturing Unit: Vapi, Gujarat | Corporate Office: Mumbai, Maharashtra, India
Final Words: Trust Taj Pharma – Your #1 Source for Urokinase Injection in India
With decades of pharmaceutical excellence and an unwavering commitment to quality, Taj Pharma continues to be the top choice for Urokinase Injection 5000IU (UVANTAJ). Our GMP-certified production, deep clinical insights, and international footprint ensure that every dose delivered is safe, effective, and affordable.
Partner with Taj Pharma – where global healthcare meets Indian innovation.
